Psychedelic Legalization in Arizona
Arizona has passed psychedelic-therapy legislation, but services aren't available yet — the state is still building its program and licensing framework.
Arizona has passed legislation to legalize psychedelic therapy, but services are not yet available. The state is building its regulatory framework, establishing licensing requirements, and developing program guidelines.
This is a critical window for practitioners looking to get certified early and for patients who want to understand when therapy will become available. Here's what the law says, what the timeline looks like, and how to stay informed as Arizona's program takes shape.
Getting treatment in Arizona
Whether psychedelic therapy is available here — and where to find it.
Legal Status by Substance
SB 1555 signed June 2025. Allows pharmaceutical psilocybin therapy conditional on FDA approval and DEA rescheduling by Jan 2031. DHS must begin licensing therapy centers by Jan 2027. $5M earmarked for research.
Where to access therapy
Supervised psychedelic therapy isn’t available to the public in Arizona yet. It is operating today in Oregon and Colorado, and New Mexico’s medical program is launching.
For providers: getting licensed & preparing for legalization
Arizona funds psilocybin research, not access. A $5M state program backs whole-mushroom psilocybin clinical trials, including PTSD in first responders — there is no consumer-access program.
Arizona's activity is currently research- and trial-focused rather than a consumer-access program. For clinicians, the near-term openings are in research settings and trial support — plus preparing for a future access framework that may follow.
What to do now
- Arizona’s near-term openings are in research settings (e.g., the state-funded PTSD trials), not a licensing program.
- The most concrete step available today, in any state, is ketamine-assisted psychotherapy — the one legal, broadly available psychedelic-adjacent modality clinicians can train in and practice right now. It builds the exact skills (set and setting, preparation, dosing-session support, integration) that psilocybin and MDMA programs will require.
In August 2026, SAMHSA — the federal Substance Abuse and Mental Health Services Administration — published a report urging states to begin planning for the legal, operational, and Medicaid implications of potential FDA-approved psychedelic therapies, including credentialing, safety protocols, and consent standards. Across recent federal activity, the supply of trained clinicians is consistently named as the main bottleneck to access — which is exactly what preparing early addresses.
Source: SAMHSA (2026) — Current Research, Regulatory, and Policy Considerations: Psychedelics Medicine (PEP26-01-004)Sources: Marijuana Moment (2025)
Frequently asked questions
Is psilocybin therapy legal in Arizona?
Arizona has passed psychedelic-therapy legislation, but services aren't available yet — the state is still building its program and licensing framework.
When will psychedelic therapy be legal in Arizona?
There is no guaranteed date — timelines depend on the legislature and, where a law has passed, on the rulemaking process. This page tracks Arizona's current status; watch the legislation and advisory-board updates for the clearest signal.
Can I prepare to become a psychedelic therapist in Arizona before it's legal?
Yes. You can begin training in psychedelic-assisted therapy now, build transferable clinical skills, and follow Arizona's policy process so you're ready when a program opens. The provider section on this page outlines concrete steps.